CORONARY ARTERY DISEASE, vol.25, no.7, pp.558-564, 2014 (Journal Indexed in SCI)
Objectives The aim of this study was to evaluate the prognostic value of soluble CD40 ligand (sCD40L) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing a primary percutaneous coronary intervention (PCI).